Daily Market Movers Digest Stock Alerts, Friday, June 30th, VXGN, XKEM, WDPT, PTSEF, SOEN.

Publication: M2 Presswire

Bookmark this article Print this article Link to this article Email this article Digg It! Add to del.icio.us RSS

COPYRIGHT 2006 M2 Communications Ltd.

M2 PRESSWIRE-30 June 2006-OTCPicks.com: Daily Market Movers Digest Stock Alerts, Friday, June 30th, VXGN, XKEM, WDPT, PTSEF, SOEN(C)1994-2006 M2 COMMUNICATIONS LTD

RDATE:30062006

Today our stock watch alerts today include stock alerts for VaxGen, Inc. (OTC: VXGN), Xechem International, Inc. (OTCBB: XKEM), WidePoint Corporation (OTCBB: WDPT), Points International Ltd. (OTCBB: PTSEF), and Solar Enertech Corp. (OTCBB: SOEN).

OTC STOCK ALERTS

VAXGEN, INC. (OTC: VXGN) "Up 30.99% at close on Thursday"

Detailed Quote: http://www.otcpicks.com/quotes/VXGN.php

VaxGen, Inc. (OTC: VXGN) engages in the development, manufacture, and commercialization of biologic products for the prevention and treatment of human infectious disease. The company focuses on the development and commercialization of biologic products to counter bioterrorism threats; vaccines for the long-term prevention of anthrax, plague, and smallpox; and a monoclonal antibody for the treatment and short-term prevention of anthrax disease. It has completed two Phase III clinical trials of two formulations for AIDSVAX, a vaccine used to prevent infection by HIV. The company completed the Phase I randomized, single-blind, placebo-controlled, dose-ranging clinical trial of rPA102, a recombinant Protective Antigen anthrax vaccine candidate. The company in collaboration with Chemo-Sero Therapeutic Research Institute is developing LC16m8, an attenuated live virus smallpox vaccine candidate for use in United States. VaxGen has a cross-license and cooperative research agreement with AVANIR Pharmaceuticals. VaxGen was founded in 1995 and is headquartered in Brisbane, California.

VXGN News:

June 29 - VaxGen, seeking cash, sells some Celltrion shares for $79M

Vaccine maker VaxGen Inc. sold some of its interest in South Korea's Celltrion Inc. for $79 million in a bid to raise enough cash to keep operating next year.

Brisbane-based VaxGen (Pink Sheets: VXGN) has struggled to change its...

Read the full article for free courtesy of your local library.